No Data
No Data
Honeywell, Sherwin-Williams Co. Share Gains Lead Dow's 232-Point Jump
Express News | Merck & Co: Laboratory Component Is Expected to Be Fully Operational by 2028, With Production of Investigational Compounds to Start by 2030
Express News | Merck & Co Inc: Merck Wilmington Biotech Will Serve as a Launch and Commercial Production Facility and Future U.S. Home for Keytruda
Express News | Merck & Co Inc - New Facility to Create 500 Full-Time Roles and 4,000 Jobs
Express News | Merck Breaks Ground on New $1 Billion Biologics Center of Excellence in Wilmington, Delaware
Merck (MRK.US) plans to invest 1 billion USD to build a factory in the USA to ensure the supply of Keytruda is protected from tariff impacts.
Merck will invest 1 billion dollars to build a factory in Delaware to ensure the domestic supply of Keytruda.